122 related articles for article (PubMed ID: 27470556)
1. Gene expression profiling of common signal transduction pathways affected by rBMSCs/F92A-Cav1 in the lungs of rat with pulmonary arterial hypertension.
Chen H; Yang H; Xu C; Yue H; Xia P; Strappe PM; Wang L; Pan L; Tang W; Chen S; Wang L
Biomed Pharmacother; 2016 Oct; 83():100-106. PubMed ID: 27470556
[TBL] [Abstract][Full Text] [Related]
2. Mesenchymal Stem Cells Expressing eNOS and a Cav1 Mutant Inhibit Vascular Smooth Muscle Cell Proliferation in a Rat Model of Pulmonary Hypertension.
Chen H; Yang H; Yue H; Strappe PM; Xia P; Pan L; Zhang Y; Chai S; Chen S; Ma L; Wang L
Heart Lung Circ; 2017 May; 26(5):509-518. PubMed ID: 27771236
[TBL] [Abstract][Full Text] [Related]
3. Dissecting Molecular Mechanisms Underlying Pulmonary Vascular Smooth Muscle Cell Dedifferentiation in Pulmonary Hypertension: Role of Mutated Caveolin-1 (Cav1
Yu W; Chen H; Yang H; Ding J; Xia P; Mei X; Wang L; Chen S; Zou C; Wang LX
Heart Lung Circ; 2019 Oct; 28(10):1587-1597. PubMed ID: 30262154
[TBL] [Abstract][Full Text] [Related]
4. The stimulatory effects of eNOS/F92A-Cav1 on NO production and angiogenesis in BMSCs.
Xia P; Chen HY; Chen SF; Wang L; Strappe PM; Yang HL; Zhou CH; Zhang X; Zhang YX; Ma LL; Wang L
Biomed Pharmacother; 2016 Feb; 77():7-13. PubMed ID: 26796258
[TBL] [Abstract][Full Text] [Related]
5. rBMSC/Cav-1
Yu WC; Chen HY; Yang HL; Xia P; Zou CW; Sun TW; Wang LX
Stem Cells Int; 2019; 2019():6768571. PubMed ID: 31781243
[TBL] [Abstract][Full Text] [Related]
6. Molecular control of nitric oxide synthesis through eNOS and caveolin-1 interaction regulates osteogenic differentiation of adipose-derived stem cells by modulation of Wnt/β-catenin signaling.
Bandara N; Gurusinghe S; Lim SY; Chen H; Chen S; Wang D; Hilbert B; Wang LX; Strappe P
Stem Cell Res Ther; 2016 Dec; 7(1):182. PubMed ID: 27927230
[TBL] [Abstract][Full Text] [Related]
7. Mesenchymal stromal cell therapy reduces lung inflammation and vascular remodeling and improves hemodynamics in experimental pulmonary arterial hypertension.
de Mendonça L; Felix NS; Blanco NG; Da Silva JS; Ferreira TP; Abreu SC; Cruz FF; Rocha N; Silva PM; Martins V; Capelozzi VL; Zapata-Sudo G; Rocco PRM; Silva PL
Stem Cell Res Ther; 2017 Oct; 8(1):220. PubMed ID: 28974252
[TBL] [Abstract][Full Text] [Related]
8. Abnormal expression of vesicular transport proteins in pulmonary arterial hypertension in monocrotaline-treated rats.
Zhang H; Luo Q; Liu Z; Wang Y; Zhao Z
Acta Biochim Biophys Sin (Shanghai); 2015 Mar; 47(3):156-63. PubMed ID: 25630652
[TBL] [Abstract][Full Text] [Related]
9. Protection against monocrotaline-induced pulmonary arterial hypertension and caveolin-1 downregulation by fluvastatin in rats.
Zhu S; Wang J; Wang X; Zhao J
Mol Med Rep; 2018 Mar; 17(3):3944-3950. PubMed ID: 29286128
[TBL] [Abstract][Full Text] [Related]
10. rBMSCs/ITGA5B1 Promotes Human Vascular Smooth Muscle Cell Differentiation via Enhancing Nitric Oxide Production.
Zhang Y; Ding J; Xu C; Yang H; Xia P; Ma S; Chen H
Int J Stem Cells; 2018 Nov; 11(2):168-176. PubMed ID: 30497129
[TBL] [Abstract][Full Text] [Related]
11. Minicircle DNA-mediated endothelial nitric oxide synthase gene transfer enhances angiogenic responses of bone marrow-derived mesenchymal stem cells.
Bandara N; Gurusinghe S; Chen H; Chen S; Wang LX; Lim SY; Strappe P
Stem Cell Res Ther; 2016 Apr; 7():48. PubMed ID: 27036881
[TBL] [Abstract][Full Text] [Related]
12. Type I interferon activation and endothelial dysfunction in caveolin-1 insufficiency-associated pulmonary arterial hypertension.
Gairhe S; Awad KS; Dougherty EJ; Ferreyra GA; Wang S; Yu ZX; Takeda K; Demirkale CY; Torabi-Parizi P; Austin ED; Elinoff JM; Danner RL
Proc Natl Acad Sci U S A; 2021 Mar; 118(11):. PubMed ID: 33836561
[TBL] [Abstract][Full Text] [Related]
13. Caveolin-1 scaffolding domain residue phenylalanine 92 modulates Akt signaling.
Trane AE; Hiob MA; Uy T; Pavlov D; Bernatchez P
Eur J Pharmacol; 2015 Nov; 766():46-55. PubMed ID: 26409042
[TBL] [Abstract][Full Text] [Related]
14. Rescue of monocrotaline-induced pulmonary arterial hypertension using bone marrow-derived endothelial-like progenitor cells: efficacy of combined cell and eNOS gene therapy in established disease.
Zhao YD; Courtman DW; Deng Y; Kugathasan L; Zhang Q; Stewart DJ
Circ Res; 2005 Mar; 96(4):442-50. PubMed ID: 15692087
[TBL] [Abstract][Full Text] [Related]
15. Deficiency of cold-inducible RNA-binding protein exacerbated monocrotaline-induced pulmonary artery hypertension through Caveolin1 and CAVIN1.
Liu J; Ke X; Wang L; Zhang Y; Yang J
J Cell Mol Med; 2021 May; 25(10):4732-4743. PubMed ID: 33755319
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of nuclear factor-κB in the lungs prevents monocrotaline-induced pulmonary hypertension in mice.
Li L; Wei C; Kim IK; Janssen-Heininger Y; Gupta S
Hypertension; 2014 Jun; 63(6):1260-9. PubMed ID: 24614212
[TBL] [Abstract][Full Text] [Related]
17. Endothelial-to-mesenchymal transition in pulmonary hypertension.
Ranchoux B; Antigny F; Rucker-Martin C; Hautefort A; Péchoux C; Bogaard HJ; Dorfmüller P; Remy S; Lecerf F; Planté S; Chat S; Fadel E; Houssaini A; Anegon I; Adnot S; Simonneau G; Humbert M; Cohen-Kaminsky S; Perros F
Circulation; 2015 Mar; 131(11):1006-18. PubMed ID: 25593290
[TBL] [Abstract][Full Text] [Related]
18. Endothelial nitric oxide synthase-enhancing G-protein coupled receptor antagonist inhibits pulmonary artery hypertension by endothelin-1-dependent and endothelin-1-independent pathways in a monocrotaline model.
Liu CP; Dai ZK; Huang CH; Yeh JL; Wu BN; Wu JR; Chen IJ
Kaohsiung J Med Sci; 2014 Jun; 30(6):267-78. PubMed ID: 24835346
[TBL] [Abstract][Full Text] [Related]
19. Tetrandrine prevents monocrotaline-induced pulmonary arterial hypertension in rats through regulation of the protein expression of inducible nitric oxide synthase and cyclic guanosine monophosphate-dependent protein kinase type 1.
Wang X; Yang Y; Yang D; Tong G; Lv S; Lin X; Chen C; Dong W
J Vasc Surg; 2016 Nov; 64(5):1468-1477. PubMed ID: 26527422
[TBL] [Abstract][Full Text] [Related]
20. Integrin alpha5beta1 suppresses rBMSCs anoikis and promotes nitric oxide production.
Chen HY; Pan L; Yang HL; Xia P; Yu WC; Tang WQ; Zhang YX; Chen SF; Xue YZ; Wang LX
Biomed Pharmacother; 2018 Mar; 99():1-8. PubMed ID: 29324307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
